Annual Total Assets
$470.11 M
+$94.48 M+25.15%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual total assets is currently $470.11 million, with the most recent change of +$94.48 million (+25.15%) on 31 December 2023. During the last 3 years, it has risen by +$277.76 million (+144.40%). CPRX annual total assets is now at all-time high.CPRX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$772.01 M
+$65.65 M+9.29%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly total assets is currently $772.01 million, with the most recent change of +$65.65 million (+9.29%) on 30 September 2024. Over the past year, it has increased by +$358.80 million (+86.83%). CPRX quarterly total assets is now at all-time high.CPRX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.1% | +86.8% |
| 3 y3 years | +144.4% | +245.8% |
| 5 y5 years | +677.7% | +698.4% |
CPRX Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +144.4% | at high | +245.8% |
| 5 y | 5 years | at high | +677.7% | at high | +698.4% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Catalyst Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $772.01 M(+9.3%) |
| June 2024 | - | $706.36 M(+9.2%) |
| Mar 2024 | - | $646.68 M(+37.6%) |
| Dec 2023 | $470.11 M(+25.2%) | $470.11 M(+13.8%) |
| Sept 2023 | - | $413.21 M(-6.9%) |
| June 2023 | - | $443.90 M(+9.0%) |
| Mar 2023 | - | $407.23 M(+8.4%) |
| Dec 2022 | $375.63 M(+58.0%) | $375.63 M(+12.8%) |
| Sept 2022 | - | $333.11 M(+24.6%) |
| June 2022 | - | $267.31 M(+8.2%) |
| Mar 2022 | - | $246.97 M(+3.9%) |
| Dec 2021 | $237.79 M(+23.6%) | $237.79 M(+6.5%) |
| Sept 2021 | - | $223.25 M(+6.8%) |
| June 2021 | - | $209.13 M(+6.0%) |
| Mar 2021 | - | $197.22 M(+2.5%) |
| Dec 2020 | $192.35 M(+71.2%) | $192.35 M(+10.0%) |
| Sept 2020 | - | $174.86 M(+33.1%) |
| June 2020 | - | $131.41 M(+11.5%) |
| Mar 2020 | - | $117.88 M(+4.9%) |
| Dec 2019 | $112.38 M(+85.9%) | $112.38 M(+16.2%) |
| Sept 2019 | - | $96.69 M(+23.6%) |
| June 2019 | - | $78.23 M(+28.1%) |
| Mar 2019 | - | $61.08 M(+1.0%) |
| Dec 2018 | $60.45 M(-29.2%) | $60.45 M(-10.7%) |
| Sept 2018 | - | $67.71 M(-8.9%) |
| June 2018 | - | $74.29 M(-6.1%) |
| Mar 2018 | - | $79.13 M(-7.3%) |
| Dec 2017 | $85.39 M(+104.7%) | $85.39 M(+146.6%) |
| Sept 2017 | - | $34.63 M(-3.7%) |
| June 2017 | - | $35.98 M(-4.6%) |
| Mar 2017 | - | $37.70 M(-9.6%) |
| Dec 2016 | $41.71 M(-30.6%) | $41.71 M(-8.0%) |
| Sept 2016 | - | $45.31 M(-7.4%) |
| June 2016 | - | $48.94 M(-8.8%) |
| Mar 2016 | - | $53.67 M(-10.7%) |
| Dec 2015 | $60.10 M | $60.10 M(-6.9%) |
| Sept 2015 | - | $64.56 M(-5.5%) |
| June 2015 | - | $68.34 M(-10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $76.05 M(+73.2%) |
| Dec 2014 | $43.91 M(+73.1%) | $43.91 M(-4.2%) |
| Sept 2014 | - | $45.84 M(-0.2%) |
| June 2014 | - | $45.93 M(+106.6%) |
| Mar 2014 | - | $22.23 M(-12.4%) |
| Dec 2013 | $25.37 M(+51.1%) | $25.37 M(-11.6%) |
| Sept 2013 | - | $28.70 M(+128.7%) |
| June 2013 | - | $12.55 M(-13.3%) |
| Mar 2013 | - | $14.47 M(-13.8%) |
| Dec 2012 | $16.79 M(+168.7%) | $16.79 M(+38.7%) |
| Sept 2012 | - | $12.11 M(+57.1%) |
| June 2012 | - | $7.70 M(+54.4%) |
| Mar 2012 | - | $4.99 M(-20.2%) |
| Dec 2011 | $6.25 M(+7.2%) | $6.25 M(+45.4%) |
| Sept 2011 | - | $4.30 M(-23.4%) |
| June 2011 | - | $5.61 M(-21.6%) |
| Mar 2011 | - | $7.16 M(+22.7%) |
| Dec 2010 | $5.83 M(-26.8%) | $5.83 M(-9.1%) |
| Sept 2010 | - | $6.42 M(+8.5%) |
| June 2010 | - | $5.91 M(-16.0%) |
| Mar 2010 | - | $7.04 M(-11.7%) |
| Dec 2009 | $7.97 M(-33.8%) | $7.97 M(+56.9%) |
| Sept 2009 | - | $5.08 M(-21.7%) |
| June 2009 | - | $6.48 M(-29.9%) |
| Mar 2009 | - | $9.25 M(-23.1%) |
| Dec 2008 | $12.03 M(-27.9%) | $12.03 M(-21.6%) |
| Sept 2008 | - | $15.35 M(+13.4%) |
| June 2008 | - | $13.53 M(-12.6%) |
| Mar 2008 | - | $15.49 M(-7.1%) |
| Dec 2007 | $16.68 M(-19.1%) | $16.68 M(-5.2%) |
| Sept 2007 | - | $17.59 M(-3.6%) |
| June 2007 | - | $18.25 M(-5.8%) |
| Mar 2007 | - | $19.38 M(-6.0%) |
| Dec 2006 | $20.62 M(+2512.0%) | $20.62 M(+487.1%) |
| Sept 2006 | - | $3.51 M(+861.9%) |
| June 2006 | - | $365.10 K(-53.7%) |
| Dec 2005 | $789.40 K(+325.8%) | $789.40 K(+325.8%) |
| Dec 2004 | $185.40 K(+66.1%) | $185.40 K |
| Dec 2002 | $111.60 K | - |
FAQ
- What is Catalyst Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual total assets year-on-year change?
- What is Catalyst Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly total assets year-on-year change?
What is Catalyst Pharmaceuticals annual total assets?
The current annual total assets of CPRX is $470.11 M
What is the all time high annual total assets for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual total assets is $470.11 M
What is Catalyst Pharmaceuticals annual total assets year-on-year change?
Over the past year, CPRX annual total assets has changed by +$94.48 M (+25.15%)
What is Catalyst Pharmaceuticals quarterly total assets?
The current quarterly total assets of CPRX is $772.01 M
What is the all time high quarterly total assets for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly total assets is $772.01 M
What is Catalyst Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, CPRX quarterly total assets has changed by +$358.80 M (+86.83%)